Weight Reduction by Sibutramine in Obese Subjects in Primary Care Medicine: The S. A. T. Study - Concepedia

Concepedia

Publication | Closed Access

Weight Reduction by Sibutramine in Obese Subjects in Primary Care Medicine: The S. A. T. Study

71

Citations

0

References

2004

Year

Hans Hauner, M Meier, G Wendland, Thomas Kurscheid, Karl W. Lauterbach

Experimental and Clinical Endocrinology & Diabetes

Abstract

Under primary care conditions, sibutramine 15 mg daily proved to be a safe and effective drug for additional weight loss in obese subjects undergoing a comprehensive weight reduction program.